Rationale and design of the balANZ trial: A randomised controlled trial of low GDP neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function

摘要

BackgroundThe main hypothesis of this study is that neutral pH, low glucose degradation product (GDP) peritoneal dialysis (PD) fluid better preserves residual renal function in PD patients over time compared with conventional dialysate.